The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: A literature review

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 7, 2014, Pages 1065-1079

  Torres, A ^a   Blasi, F ^b   Peetermans, W E ^c   Viegi, G ^d,e   Welte, T ^f  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^e CNR   (Italy)

^f HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; ERYTHROMYCIN; MACROLIDE; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ADULT DISEASE; ALCOHOLISM; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIUM ISOLATE; BLOOD CULTURE; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CHLAMYDOPHILA PSITTACI; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; COXIELLA BURNETII; DENMARK; ENTEROBACTERIACEAE; ESCHERICHIA COLI; EUROPE; FRANCE; GERIATRIC PATIENT; GERMANY; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; KLEBSIELLA PNEUMONIAE; LEGIONELLA PNEUMOPHILA; LIFESTYLE; LIVER DISEASE; MICROBIOLOGICAL EXAMINATION; MONOTHERAPY; MORAXELLA CATARRHALIS; MYCOPLASMA PNEUMONIAE; OUTPATIENT CARE; PATHOGENESIS; PENICILLIN RESISTANCE; PLEURA FLUID; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY VIRUS; REVIEW; SEROLOGY; SPAIN; SPUTUM CULTURE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; UNITED KINGDOM; URINE; ADOLESCENT; ADULT; AGE; AGED; BACTERIA; CLASSIFICATION; COMMUNITY-ACQUIRED INFECTIONS; DRUG EFFECTS; EPIDEMIOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIA; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; EUROPE; HUMANS; MIDDLE AGED; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; YOUNG ADULT;

EID: 84903815598     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2067-1     Document Type: Review

References (68)

1. Welte T, Torres A, Nathwani D (2012) Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 67:71-79
2. Baik I, Curhan GC, Rimm EB, Bendich A, Willett WC, Fawzi WW (2000) A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women. Arch Intern Med 160:3082-3088
3. Koivula I, Sten M, Mäkelä PH (1994) Risk factors for pneumonia in the elderly. Am J Med 96:313-320 (Pubitemid 24127266)
4. Mannino DM, Davis KJ, Kiri VA (2009) Chronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohort. Respir Med 103:224-229
5. Polverino E, Torres Marti A (2011) Community-acquired pneumonia. Minerva Anestesiol 77:196-211
6. Cillóniz C, Polverino E, Ewig S, Aliberti S, Gabarrús A, Menéndez R, Mensa J, Blasi F, Torres A (2013) Impact of age and comorbidity on cause and outcome in community-acquired pneumonia. Chest 144:999-1007
7. Torres A, Peetermans WE, Viegi G, Blasi F (2013) Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax 68:1057-1065
8. Blasi F, Mantero M, Santus P, Tarsia P (2012) Understanding the burden of pneumococcal disease in adults. Clin Microbiol Infect 18:7-14
9. Almirall J, Bolíbar I, Vidal J, Sauca G, Coll P, Niklasson B, Bartolomé M, Balanzó X (2000) Epidemiology of communityacquired pneumonia in adults: a population-based study. Eur Respir J 15:757-763 (Pubitemid 30196306)
10. Ewig S, Birkner N, Strauss R, Schaefer E, Pauletzki J, Bischoff H, Schraeder P, Welte T, Hoeffken G (2009) New perspectives on community-acquired pneumonia in 388,406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax 64:1062-1069
11. Trotter CL, Stuart JM, George R, Miller E (2008) Increasing hospital admissions for pneumonia, England. Emerg Infect Dis 14:727-733 (Pubitemid 351838635)
12. Rozenbaum MH, Pechlivanoglou P, van der Werf TS, Lo-Ten-Foe JR, Postma MJ, Hak E (2013) The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a metaanalysis. Eur J Clin Microbiol Infect Dis 32:305-316
13. Weber D, Berger A, Edelsberg J, Huang X-Y, Oster G (2011) Distribution of pathogens in patients hospitalised for communityacquired pneumonia: analysis of data from US hospitals 2006-2009. In: Proceedings of the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA), October 20-23, 2011, Boston, MA, USA
14. Cunha BA (2008) Atypical pneumonias: current clinical concepts focusing on Legionnaires' disease. Curr Opin Pulm Med 14:183-194
15. Defres S, Marwick C, Nathwani D (2009) MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia. Eur Respir J 34:1470-1476
16. Strålin K, Söderquist B (2006) Staphylococcus aureus in communityacquired pneumonia. Chest 130:623
17. Vardakas KZ, Matthaiou DK, Falagas ME (2009) Incidence, characteristics and outcomes of patients with severe community acquired- MRSA pneumonia. Eur Respir J 34:1148-1158
18. Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ; Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases (2011) Guidelines for the management of adult lower respiratory tract infections - full version. Clin Microbiol Infect 17(Suppl 6):E1-E59
19. Lim WS, Macfarlane JT, Boswell TC, Harrison TG, Rose D, Leinonen M, Saikku P (2001) Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 56:296-301 (Pubitemid 32269810)
20. Garcia-Vidal C, Fernández-Sabé N, Carratalà J, Díaz V, Verdaguer R, Dorca J, Manresa F, Gudiol F (2008) Early mortality in patients with community-acquired pneumonia: causes and risk factors. Eur Respir J 32:733-739
21. Lujan M, Gallego M, Fontanals D, Mariscal D, Rello J (2004) Prospective observational study of bacteremic pneumococcal pneumonia: effect of discordant therapy on mortality. Crit Care Med 32:625-631 (Pubitemid 38340054)
22. Cillóniz C, Ewig S, Ferrer M, Polverino E, Gabarrús A, Puig de la Bellacasa J, Mensa J, Torres A (2011) Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis. Crit Care 15:R209
23. Kothe H, Bauer T, Marre R, Suttorp N, Welte T, Dalhoff K; Competence Network for Community-Acquired Pneumonia study group (2008) Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur Respir J 32:139-146
24. Almirall J, Rofes L, Serra-Prat M, Icart R, Palomera E, Arreola V, Clavé P (2013) Oropharyngeal dysphagia is a risk factor for community-acquired pneumonia in the elderly. Eur Respir J 41:923-928
25. Cabre M, Serra-Prat M, Palomera E, Almirall J, Pallares R, Clavé P (2010) Prevalence and prognostic implications of dysphagia in elderly patients with pneumonia. Age Ageing 39:39-45
26. Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, Raga-Luria X, Gomez-Bertomeu F; EPIVAC Study Group (2009) Epidemiology of community-acquired pneumonia in older adults: a populationbased study. Respir Med 103:309-316
27. Chidiac C, Che D, Pires-Cronenberger S, Jarraud S, Campèse C, Bissery A, Weinbreck P, Brun-Buisson C, Sollet JP, Ecochard R, Desenclos JC, Etienne J, Vanhems P; French Legionnaires' Disease Study Group (2012) Factors associated with hospital mortality in community-acquired legionellosis in France. Eur Respir J 39:963-970
28. Sopena N, Force L, Pedro-Botet ML, Barrufet P, Sauca G, García- Núñez M, Tolchinsky G, Capdevila JA, Sabrià M (2007) Sporadic and epidemic community legionellosis: two faces of the same illness. Eur Respir J 29:138-142 (Pubitemid 46092010)
29. Sopena N, Pedro-Botet L, Mateu L, Tolschinsky G, Rey-Joly C, Sabrià M (2007) Community-acquired legionella pneumonia in elderly patients: characteristics and outcome. J Am Geriatr Soc 55:114-119 (Pubitemid 46046237)
30. Kofteridis D, Samonis G, Mantadakis E, Maraki S, Chrysofakis G, Alegakis D, Papadakis J, Gikas A, Bouros D (2009) Lower respiratory tract infections caused by Haemophilus influenzae: clinical features and predictors of outcome. Med Sci Monit 15:CR135- CR139
31. Ruiz LA, Gómez A, Jaca C, Martínez L, Gómez B, Zalacain R (2010) Bacteraemic community-acquired pneumonia due to Gram-negative bacteria: incidence, clinical presentation and factors associated with severity during hospital stay. Infection 38:453-458 32.
32. von Baum H, Welte T, Marre R, Suttorp N, Ewig S; CAPNETZ study group (2010) Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: Diagnosis, incidence and predictors. Eur Respir J 35:598-605
33. Bénard A, Mercié P, Alioum A, Bonnet F, Lazaro E, Dupon M, Neau D, Dabis F, Chêne G; Groupe d'Epidémiologie Clinique du Sida en Aquitaine (2010) Bacterial pneumonia among HIV-infected patients: decreased risk after tobacco smoking cessation. ANRS CO3 Aquitaine Cohort, 2000-2007. PLoS One 5:e8896
34. Curran A, Falcó V, Crespo M, Martinez X, Ribera E, Villar del Saz S, Imaz A, Coma E, Ferrer A, Pahissa A (2008) Bacterial pneumonia in HIV-infected patients: use of the pneumonia severity index and impact of current management on incidence, aetiology and outcome. HIV Med 9:609-615
35. LeMoing V, Rabaud C, Journot V, Duval X, Cuzin L, Cassuto JP, Al Kaied F, Dellamonica P, Chêne G, Raffi F; APROCO Study Group (2006) Incidence and risk factors of bacterial pneumonia requiring hospitalization in HIV-infected patients started on a protease inhibitor-containing regimen. HIV Med 7:261-267
36. Madeddu G, Porqueddu EM, Cambosu F, Saba F, Fois AG, Pirina P, Mura MS (2008) Bacterial community acquired pneumonia in HIVinfected inpatients in the highly active antiretroviral therapy era. Infection 36:231-236
37. Manno D, Puoti M, Signorini L, Lapadula G, Cadeo B, Soavi L, Paraninfo G, Allegri R, Cristini G, Viale P, Carosi G (2009) Risk factors and clinical characteristics associated with hospitalization for community-acquired bacterial pneumonia in HIV-positive patients according to the presence of liver cirrhosis. Infection 37:334-339
38. Molinos L, Clemente MG, Miranda B, Alvarez C, del Busto B, Cocina BR, Alvarez F, Gorostidi J, Orejas C; ASTURPAR Group (2009) Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease. J Infect 58:417-424
39. Falguera M, Carratalà J, Ruiz-Gonzalez A, Garcia-Vidal C, Gazquez I, Dorca J, Gudiol F, Porcel JM (2009) Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli. Respirology 14:105-111
40. Gutiérrez F, Masiá M, Rodríguez JC, Mirete C, Soldán B, Padilla S, Hernández I, De Ory F, Royo G, Hidalgo AM (2005) Epidemiology of community-acquired pneumonia in adult patients at the dawn of the 21st century: a prospective study on the Mediterranean coast of Spain. Clin Microbiol Infect 11:788-800 (Pubitemid 41341711)
41. Klapdor B, Ewig S, Pletz MW, Rohde G, Schütte H, Schaberg T, Welte T; CAPNETZ Study Group (2012) Community-acquired pneumonia in younger patients is an entity on its own. Eur Respir J 39:1156-1161
42. Liapikou A, Polverino E, Ewig S, Cillóniz C, Marcos MA, Mensa J, Bello S, Martin-Loeches I, Menéndez R, Torres A (2012) Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients. Eur Respir J 39:855-861
43. Carratalà J, Mykietiuk A, Fernández-Sabé N, Suárez C, Dorca J, Verdaguer R, Manresa F, Gudiol F (2007) Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 167:1393-1399 (Pubitemid 47052438)
44. Cillóniz C, Ewig S, Polverino E, Muñoz-Almagro C, Marco F, Gabarrús A, Menéndez R, Mensa J, Torres A (2012) Pulmonary complications of pneumococcal community-acquired pneumonia: incidence, predictors, and outcomes. Clin Microbiol Infect 18:1134-1142
45. de Roux A, Cavalcanti M, Marcos MA, Garcia E, Ewig S, Mensa J, Torres A (2006) Impact of alcohol abuse in the etiology and severity of community-acquired pneumonia. Chest 129:1219-1225
46. Viasus D, Garcia-Vidal C, Castellote J, Adamuz J, Verdaguer R, Dorca J, Manresa F, Gudiol F, Carratalà J (2011) Communityacquired pneumonia in patients with liver cirrhosis: clinical features, outcomes, and usefulness of severity scores. Medicine (Baltimore) 90:110-118
47. Viegi G, Pistelli R, Cazzola M, Falcone F, Cerveri I, Rossi A, Ugo Di Maria G (2006) Epidemiological survey on incidence and treatment of community acquired pneumonia in Italy. Respir Med 100:46-55 (Pubitemid 43033379)
48. Garcia-Vidal C, Carratalà J, Fernández-Sabé N, Dorca J, Verdaguer R, Manresa F, Gudiol F (2009) Aetiology of, and risk factors for, recurrent community-acquired pneumonia. Clin Microbiol Infect 15:1033-1038
49. Giannella M, Pinilla B, Capdevila JA, Martínez Alarcón J, Muñoz P, López Álvarez J, Bouza E; Estudio de Neumonía En Medicina Interna study Group from the Sociedad Española de Medicina Interna (2012) Pneumonia treated in the internal medicine department: focus on healthcare-associated pneumonia. Clin Microbiol Infect 18:786-794
50. Viasus D, Garcia-Vidal C, Cruzado JM, Adamuz J, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J (2011) Epidemiology, clinical features and outcomes of pneumonia in patients with chronic kidney disease. Nephrol Dial Transplant 26:2899-2906
51. Reissig A, Mempel C, Schumacher U, Copetti R, Gross F, Aliberti S (2013) Microbiological diagnosis and antibiotic therapy in patients with community-acquired pneumonia and acute COPD exacerbation in daily clinical practice: comparison to current guidelines. Lung 191:239-246
52. Blasi F, Garau J, Medina J, Avila M, McBride K, Ostermann H (2013) Current management of patients hospitalized with community-acquired pneumonia across Europe: outcomes from REACH. Respir Res 14:44
53. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, Torres A, Whitney CG; Infectious Diseases Society of America; American Thoracic Society (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(Suppl 2):S27-S72 (Pubitemid 46290553)
54. Jokinen C, Heiskanen L, Juvonen H, Kallinen S, Kleemola M, Koskela M, Leinonen M, Rönnberg PR, Saikku P, Stén M, Tarkiainen A, Tukiainen H, Pyörälä K, Mäkelä PH (2001) Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland. Clin Infect Dis 32:1141-1154 (Pubitemid 32381120)
55. Aliberti S, Cilloniz C, Chalmers JD, Zanaboni AM, Cosentini R, Tarsia P, Pesci A, Blasi F, Torres A (2013) Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective. Thorax 68:997-999
56. Christensen D, Feldman C, Rossi P, Marrie T, Blasi F, Luna C, Fernandez P, Porras J, Martinez J, Weiss K, Levy G, Lode H, Gross P, File T, Ramirez J; Community-Acquired Pneumonia Organization Investigators (2005) HIV infection does not influence clinical outcomes in hospitalized patients with bacterial community-acquired pneumonia: results from the CAPO international cohort study. Clin Infect Dis 41:554-556 (Pubitemid 41099654)
57. Malinis M, Myers J, Bordon J, Peyrani P, Kapoor R, Nakamatzu R, Lopardo G, Torres A, Feldman C, Allen M, Arnold F, Ramirez J (2010) Clinical outcomes of HIV-infected patients hospitalized with bacterial community-acquired pneumonia. Int J Infect Dis 14:e22-e27
58. Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, Macfarlane JT, Read RC, Roberts HJ, Levy ML, Wani M, Woodhead MA; Pneumonia Guidelines Committee of the BTS Standards of Care Committee (2009) BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 64(Suppl 3):iii1-iii55
59. Menéndez R, Torres A, Aspa J, Capelastegui A, Prat C, Rodríguez de Castro F; Sociedad Española de Neumología y Cirugía Torácica (2010) Community acquired pneumonia. New guidelines of the Spanish Society of Chest Diseases and Thoracic Surgery (SEPAR). Arch Bronconeumol 46:543-558
60. Höffken G, Lorenz J, Kern W, Welte T, Bauer T, Dalhoff K, Dietrich E, Ewig S, Gastmeier P, Grabein B, Halle E, Kolditz M, Marre R, Sitter H; Paul-Ehrlich-Society of Chemotherapy; German Respiratory Diseases Society; German Infectious Diseases Society; Competence Network CAPNETZ for the Management of Lower Respiratory Tract Infections and Community-acquired Pneumonia (2010) Guidelines of the Paul-Ehrlich-Society of Chemotherapy, the German Respiratory Diseases Society, the German Infectious Diseases Society and of the Competence Network CAPNETZ for the Management of Lower Respiratory Tract Infections and Community-acquired Pneumonia. Pneumologie 64:149-154
61. Blasi F, Bulfoni A, Concia E, Costantino S, Di Rosa S, Iori I, Mazzei T, Schito GC (2002) Gestione delle infezioni delle basse vie respiratorie in medicina interna. GIMI 1:1-69
62. Blasi F, Bulfoni A, Concia E, Costantino S, Giusti M, Iori I, Mazzei T, Schito GC (2010) Attualità nella gestione delle infezioni delle basse vie respiratorie in medicina interna. Ital J Med 4:1-78
63. Torres A, Barberán J, Falguera M, Menéndez R, Molina J, Olaechea P, Rodríguez A; Grupo de la Guía Multidisciplinar para el Manejo de la Neumonía Adquirida en la Comunidad (2013) Multidisciplinary guidelines for the management of community-acquired pneumonia. Med Clin (Barc) 140:223.e1-223.e19
64. European Centre for Disease Prevention and Control (ECDC) (2012) Antimicrobial resistance surveillance in Europe 2011. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Available online at: http://www.ecdc.europa.eu/en/ publications/Publications/ antimicrobial-resistance-surveillance-europe- 2011.pdf. Accessed 2 September 2013
65. Holm A, Nexoe J, Bistrup LA, Pedersen SS, Obel N, Nielsen LP, Pedersen C (2007) Aetiology and prediction of pneumonia in lower respiratory tract infection in primary care. Br J Gen Pract 57:547-554 (Pubitemid 47039501)
66. Migliorati PL, Boccoli E, Bracci LS, Sestini P, Melani AS (2006) A survey on hospitalised community-acquired pneumonia in Italy. Monaldi Arch Chest Dis 65:82-88 (Pubitemid 44209758)
67. Pérez-Sola MJ, Torre-Cisneros J, Pérez-Zafrilla B, Carmona L, Descalzo MA, Gómez-Reino JJ; BIOBADASER Study Group (2011) Infections in patients treated with tumor necrosis factor antagonists: incidence, etiology and mortality in the BIOBADASER registry. Med Clin (Barc) 137:533-540
68. Bewick T, Sheppard C, Greenwood S, Slack M, Trotter C, George R, Lim WS (2012) Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia. Thorax 67:540-545